1.
Tunisie Medicale [La]. 2004; 82 (4): 393-396
em Francês
| IMEMR
| ID: emr-206060
RESUMO
We report the first tunisian case of miliary tuberculosis in a patient who received Infliximab for Crohn's disease with uretrorectal and ano-perineal fistula developed 4 weeks after the start of treatment. We suggest that diagnosis of latent tuberculosis infection is important before treatment with Infliximab is initiated and that antituberculous medication must be prescribed immediatly in case of occurrence of unexplained fever after treatment with Infliximab